{
  "id": "d6133b2fa90a3ffc",
  "title": "STAT+: \u2018Remarkable\u2019 drug results against an aggressive leukemia",
  "description": "At the end of a tense year for science, the American Society of Hematology heard promising data on acute myeloid leukemia, Von Willebrand disease and more.",
  "content": "At the end of a tense year for science, the American Society of Hematology heard promising data on acute myeloid leukemia, Von Willebrand disease and more.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2025/12/06/ash-meeting-syndax-drug-for-acute-myeloid-leukemia/?utm_campaign=rss",
  "published_at": "2025-12-06T20:26:30+00:00",
  "fetched_at": "2025-12-07T00:25:01.471764+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: \u2018Remarkable\u2019 drug results against an aggressive leukemia",
    "description": "At the end of a tense year for science, the American Society of Hematology heard promising data on acute myeloid leukemia, Von Willebrand disease and more.",
    "url": "https://www.statnews.com/2025/12/06/ash-meeting-syndax-drug-for-acute-myeloid-leukemia/?utm_campaign=rss",
    "published": "2025-12-06T20:26:30+00:00",
    "source": "STAT"
  }
}